235 related articles for article (PubMed ID: 16894081)
21. Psychotropic drug use among Icelandic children: a nationwide population-based study.
Zoëga H; Baldursson G; Hrafnkelsson B; Almarsdóttir AB; Valdimarsdóttir U; Halldórsson M
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):757-64. PubMed ID: 20035594
[TBL] [Abstract][Full Text] [Related]
22. Investigating geographic variation in use of psychotropic medications among youth in child welfare.
Leslie LK; Raghavan R; Hurley M; Zhang J; Landsverk J; Aarons G
Child Abuse Negl; 2011 May; 35(5):333-42. PubMed ID: 21620160
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.
Lyons JS; MacIntyre JC; Lee ME; Carpinello S; Zuber MP; Fazio ML
Community Ment Health J; 2004 Apr; 40(2):101-18. PubMed ID: 15206636
[TBL] [Abstract][Full Text] [Related]
24. Psychotropic medication utilization in a child and adolescent mental health service.
Dean AJ; McDermott BM; Marshall RT
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):273-85. PubMed ID: 16768635
[TBL] [Abstract][Full Text] [Related]
25. Psychotropic medication use among Kansas Medicaid youths with disabilities.
Shireman TI; Reichard A; Rigler SK
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):107-15. PubMed ID: 15741792
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.
Dusetzina SB; Weinberger M; Gaynes BN; Farley JF; Sleath B; Hansen RA
Pharmacotherapy; 2012 Dec; 32(12):1085-94. PubMed ID: 23208835
[TBL] [Abstract][Full Text] [Related]
27. Age-related trends in psychotropic medication use among very young children in foster care.
dosReis S; Tai MH; Goffman D; Lynch SE; Reeves G; Shaw T
Psychiatr Serv; 2014 Dec; 65(12):1452-7. PubMed ID: 25082134
[TBL] [Abstract][Full Text] [Related]
28. Psychotropic medication use in French children and adolescents.
Kovess V; Choppin S; Gao F; Pivette M; Husky M; Leray E
J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):168-75. PubMed ID: 25584837
[TBL] [Abstract][Full Text] [Related]
29. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns.
Koelch M; Prestel A; Singer H; Keller F; Fegert JM; Schlack R; Hoelling H; Knopf H
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):765-70. PubMed ID: 20035595
[TBL] [Abstract][Full Text] [Related]
30. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
Spreat S; Conroy J
Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
[TBL] [Abstract][Full Text] [Related]
31. Psychotropic medication use in a national probability sample of children in the child welfare system.
Raghavan R; Zima BT; Andersen RM; Leibowitz AA; Schuster MA; Landsverk J
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):97-106. PubMed ID: 15741791
[TBL] [Abstract][Full Text] [Related]
32. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
[TBL] [Abstract][Full Text] [Related]
33. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
34. Understanding the use of psychotropic medications in the child welfare system: causes, consequences, and proposed solutions.
Alavi Z; Calleja NG
Child Welfare; 2012; 91(2):77-94. PubMed ID: 23362615
[TBL] [Abstract][Full Text] [Related]
35. Medication use in community-dwelling older people: pharmacoepidemiology of psychotropic utilisation.
Schäfers A; Martini N; Moyes S; Hayman K; Zolezzi M; McLean C; Kerse N
J Prim Health Care; 2014 Dec; 6(4):269-78. PubMed ID: 25485322
[TBL] [Abstract][Full Text] [Related]
36. Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: perspective from a developing country.
Memari AH; Ziaee V; Beygi S; Moshayedi P; Mirfazeli FS
Res Dev Disabil; 2012; 33(2):563-9. PubMed ID: 22119705
[TBL] [Abstract][Full Text] [Related]
37. Increased risk among older veterans of prescribing psychotropic medication in the absence of psychiatric diagnoses.
Wiechers IR; Kirwin PD; Rosenheck RA
Am J Geriatr Psychiatry; 2014 Jun; 22(6):531-9. PubMed ID: 24211029
[TBL] [Abstract][Full Text] [Related]
38. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
[TBL] [Abstract][Full Text] [Related]
39. [Self-assessment of prescribing behavior of psychotropic drugs for children and adolescence. Results of a survey of established physicians].
Trott GE; Badura F; Wirth S; Friese HJ; Hollmann-Wehren B; Warnke A
Psychiatr Prax; 1995 Nov; 22(6):235-9. PubMed ID: 8570754
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
